Elite Pharmaceuticals, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Elite Pharmaceuticals, Inc. (ELTP) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 647.95 thousand shares for the 12-month period ending 2024-03-31, per its 10-K filed 2024-07-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2024-07-01
- Elite Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-06-30 was 2.33M shares, a 35.67% decline year-over-year.
- Elite Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-06-30 was 3.63M shares, a 97.58% decline year-over-year.
- Elite Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2016-06-30 was 149.83M shares.
- Elite Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 647.95K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|
| 2024-03-31 | 647.95K shares 10-K · filed 2024-07-01 | ||
| 2018-09-30 | 260.00 shares 10-Q · filed 2018-11-09 | ||
| 2018-06-30 | 2.33M shares 10-Q · filed 2018-08-09 | ||
| 2017-06-30 | 3.63M shares 10-Q · filed 2017-08-09 | ||
| 2016-06-30 | 149.83M shares 10-Q · filed 2017-08-09 |